Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.48 USD
Change Today +0.03 / 0.47%
Volume 231.8K
As of 4:30 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

senomyx inc (SNMX) Snapshot

Open
$6.40
Previous Close
$6.45
Day High
$6.68
Day Low
$6.38
52 Week High
09/12/14 - $10.11
52 Week Low
03/9/15 - $4.16
Market Cap
284.5M
Average Volume 10 Days
509.3K
EPS TTM
$-0.34
Shares Outstanding
43.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SENOMYX INC (SNMX)

senomyx inc (SNMX) Related Bloomberg News

View More Bloomberg News

senomyx inc (SNMX) Related Businessweek News

View More BusinessWeek News

senomyx inc (SNMX) Details

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients for the packaged food, beverage, and ingredient supply industries using proprietary taste receptor-based assays and screening technologies. The company focuses on the discovery, development, and/or commercialization of flavor ingredients through five programs focused on sweet, savory, bitter, cooling, and salt taste areas. It licenses flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The company has product discovery, development, and commercialization collaborative agreements with Ajinomoto Co., Inc., Firmenich SA, Nestlé SA, and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

110 Employees
Last Reported Date: 02/26/15
Founded in 1998

senomyx inc (SNMX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Executive Chairman
Total Annual Compensation: $4.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $349.2K
Chief Scientific Officer and Senior Vice Pres...
Total Annual Compensation: $386.3K
Chief Commercial Development Officer and Seni...
Total Annual Compensation: $362.6K
Compensation as of Fiscal Year 2014.

senomyx inc (SNMX) Key Developments

Senomyx Announces First Commercialization of Sweetmyx S617

Senomyx Inc. announced the first commercialization of Sweetmyx S617 was achieved. Senomyx has two partners on its Sweet Taste Program. PepsiCo has exclusive rights to use new flavor ingredients and natural high intensity sweeteners worldwide in non-alcoholic beverages and Firmenich has rights to commercialize new flavor ingredients for food product categories and alcoholic beverages, with exclusive rights to use Sweetmyx S617 until March 2018.

Senomyx Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Year of 2015

Senomyx Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenues of $6,213,000 compared to $7,343,000 a year ago. Loss from operations was $2,737,000 compared to $2,649,000 a year ago. Net loss was $2,728,000 or $0.06 per basic and diluted share compared to $2,641,000 or $0.06 per basic and diluted share a year ago. For the six months, the company reported total revenues of $11,219,000 compared to $15,547,000 a year ago. Loss from operations was $7,314,000 compared to $4,665,000 a year ago. Net loss was $7,297,000 or $0.17 per basic and diluted share compared to $4,649,000 or $0.11 per basic and diluted share a year ago. For the full year 2015, the company continues to expect total revenues of approximately $25 million to $30 million, of which approximately $7 million to $10 million are commercial revenues with gross margin percentage between 80% and 90%, net loss of $13 million to $15 million and basic and diluted net loss of $0.28 to $0.35 per share.

Senomyx Inc. to Report Q2, 2015 Results on Jul 30, 2015

Senomyx Inc. announced that they will report Q2, 2015 results at 11:00 AM, US Eastern Standard Time on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNMX:US $6.48 USD +0.03

SNMX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GLG Life Tech Corp C$0.30 CAD 0.00
PureCircle Ltd 395.00 GBp 0.00
Symrise AG €53.21 EUR +0.403
Takasago International Corp ¥618.00 JPY +3.00
Tate & Lyle PLC 547.50 GBp +3.50
View Industry Companies
 

Industry Analysis

SNMX

Industry Average

Valuation SNMX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.1x
Price/Book 13.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SENOMYX INC, please visit www.senomyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.